Ameritas Investment Company’s Biogen BIIB Stock Holding History

Ameritas Investment Company’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$450K	Buy	1,590 +824	+108%	+$270K	0.02%	438
2021 Q2	$435K	Sell	766 -1,296	-63%	-$393K	0.02%	450
2021 Q1	$577K	Buy	+2,062	New	+$556K	0.05%	318
2020 Q2	–	Sell	-695	Closed	-$219K	–	459
2020 Q1	$219K	Sell	695 -609	-47%	-$185K	0.04%	326
2019 Q4	$387K	Buy	1,304 +799	+158%	+$222K	0.08%	219
2019 Q3	$119K	Buy	+505	New	+$118K	0.02%	441
2019 Q2	–	Sell	-1,182	Closed	-$280K	–	294
2019 Q1	$280K	Sell	1,182 -5,775	-83%	-$1.82M	0.05%	258
2018 Q4	$2.09M	Buy	+6,957	New	+$2.22M	0.45%	49

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameritas Investment Company's BIIB Position: Q3 2021 in Review

Ameritas Investment Company increased its Biogen (BIIB) stake by 108% in Q3 2021, buying an estimated $270K and bringing the position to 1,590 shares worth $450K. The position accounts for 0.02% of the portfolio, ranked #438.

Ameritas Investment Company first reported a position in BIIB in Q4 2018 and has held it in 8 quarters since. The position peaked at $2.09M in Q4 2018. 1,040 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

Ameritas Investment Company held 1,590 shares of Biogen worth $450K as of Q3 2021.
Ameritas Investment Company bought 824 Biogen shares in Q3 2021, an estimated $270K.
Biogen made up 0.02% of Ameritas Investment Company's portfolio in Q3 2021, its #438 holding.
Ameritas Investment Company first reported a position in Biogen in Q4 2018 and has held it in 8 quarters since.
Ameritas Investment Company's Biogen position peaked at $2.09M in Q4 2018.
1,040 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.